[{"id":"4b7d48bf-777b-4cc6-8d23-6e3db810e6e6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05768321","created_at":"2023-03-14T14:01:49.188Z","updated_at":"2024-07-02T16:35:53.169Z","phase":"Phase 1","brief_title":"Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation","source_id_and_acronym":"NCT05768321","lead_sponsor":"GenEros Biopharma Hangzhou Ltd","biomarkers":" KRAS • STK11 • KEAP1","pipe":" | ","alterations":" KRAS mutation • KRAS G12C • KRAS G12","tags":["KRAS • STK11 • KEAP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • KRAS G12C • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GEC-255"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 11/04/2021","start_date":" 11/04/2021","primary_txt":" Primary completion: 02/28/2024","primary_completion_date":" 02/28/2024","study_txt":" Completion: 05/30/2024","study_completion_date":" 05/30/2024","last_update_posted":"2023-03-16"}]